Whatsapp：+85265524367
II. Central strong appetite control, prolonging the lasting feeling of fullness after meals (core feature)
Regulates hunger signals by interacting with the brainstem and hypothalamus feeding center in both directions: inhibiting the secretion of hunger-related NPY/AgRP neuropeptides, while activating the satiety POMC pathway, thereby reducing the persistent feeling of fasting hunger at its root.
Inhibits the release of dopamine in the brain's reward circuit, significantly weakening the craving for sweet foods, fried foods, etc., and improving stress-induced binge eating and emotional eating.
Significantly delays the gastric emptying speed, enhances gastric expansion tolerance, significantly prolongs the duration of post-meal satiety, autonomously reduces the total daily calorie intake, and does not rely on forced dieting for weight loss.
Different from GLP-1 substances: Both act on completely independent satiety pathways, combined use can superimpose the control effect of dieting, breaking through the weight loss plateau easily caused by single GLP-1.
II. Stabilizes blood sugar throughout the day, improves insulin resistance, inhibits liver glucose output
Glucose-dependent regulation of blood sugar: After meals, inhibits excessive secretion of glucagon by the pancreas, reduces the release of glucose by the liver, lowers the peak of post-meal blood sugar, significantly reduces the risk of hypoglycemia by about 35% PMC.
Enhances glucose uptake capacity in muscle, fat, and liver cells, reverses insulin resistance induced by obesity, improves abnormal glucose tolerance, and high fasting blood sugar.
Reduces systemic chronic inflammation caused by high sugar toxicity, reduces the conversion of sugar into visceral fat accumulation, suitable for people with abdominal obesity and abnormal blood sugar for conditioning.
Assists in steady decline of glycated hemoglobin HbA1c, long-term intervention can stabilize diabetes-related blood sugar indicators.
III. Directional decomposition of visceral fat, reshaping body composition
Prioritize the consumption of abdominal visceral fat and liver-laden lipids. In the three-phase clinical single-dose intervention, it can significantly reduce the area of visceral fat, significantly reducing waist circumference; combined with semaglutide, the average reduction in visceral fat can reach over 32%.
Gently increases the resting energy expenditure of the body, activates fatty tissue fatty acid β-oxidation, without the need for high-intensity exercise to continuously burn fat.
During the fat loss period, inhibits cortisol-mediated muscle protein breakdown, with minimal loss of lean muscle during weight loss, avoiding skin sagging and aggravation of orange peel-like wrinkles.
Inhibits the differentiation of fat precursor cells, reduces the generation of new fat cells, lowers the probability of weight loss rebound, and improves the tendency to gain weight.
IV. Reverse non-alcoholic fatty liver disease, reduce liver inflammatory damage
Reduce triglyceride and cholesterol deposition in liver cells, eliminate liver lipid infiltration, animal experiments show that it can reduce liver triglyceride content by about 35%.
Downregulates pro-inflammatory factors TNF-α and IL-6 in the liver, blocks liver fibrosis signaling pathways, alleviates mild to moderate fatty liver inflammation, improves symptoms such as heaviness in the body, morning mouth bitterness, and facial swelling caused by high fat, high sugar, and staying up late.
Optimizes lipid profile, reduces blood triglycerides and low-density lipoprotein, reduces lipid deposition on the inner wall of blood vessels.
V. Multiple cardiovascular protection, nourishing vascular endothelium
Repair vascular endothelial cells throughout the body, maintain vascular elasticity, delay the process of atherosclerosis, improve poor peripheral circulation, cold hands and feet, and insufficient blood supply to the brain causing dizziness and heavy head.
Reduces the burden on the heart caused by obesity, assists in improving metabolic-related hypertension and high cholesterol, reduces the risk of cardiovascular chronic diseases.
Reduces the continuous damage of inflammatory factors released by fat tissues to blood vessels, alleviates chronic low-grade inflammation of the entire body blood vessels.
VI. Beneficial for exercise populations: Enhance endurance, shorten recovery time
During the exercise stage, increase the proportion of fat energy supply, delay exhaustion from aerobic and strength training, extend exercise duration, improve fatigue-prone, shortness of breath, and lack of mobility.
Accelerate the elimination of lactate and fat metabolism waste, reduce delayed muscle soreness and stiffness after training, shorten the recovery time after exercise.
Balance long-term high-intensity training and high-pressure-induced cortisol persistently high levels, reduce visceral fat accumulation induced by stress hormones.
VII. Systemic anti-inflammation and antioxidant, delaying inflammatory aging Systematically reduce pro-inflammatory factors in the fat, liver, and blood vessels, improve the systemic chronic low-level inflammation caused by obesity and aging, and relieve the morning stiffness and wandering joint pain.
Remove the free radicals produced by metabolism, reduce the oxidative damage to internal organs and skin, and improve the sallow complexion and premature aging of the face in obese individuals.
VIII. Sleep and Emotional Auxiliary Regulation
Relieve the excitement and disordered cortisol caused by high appetite before bedtime, and improve the proportion of deep rest at night, and alleviate excessive dreaming and still feeling tired after waking up.
Improve the irritability and low mood caused by continuous hunger and metabolic imbalance, and reduce the cycle of binge eating driven by emotions.
Hazard Identification
Classification of the substance or mixture
GHS label elements, including precautionary statements
| Pictogram(s) | no data available |
| Signal word | no data available |
| Hazard statement(s) | no data available |
| Precautionary statement(s) |
| Prevention | no data available |
| Response | no data available |
| Storage | no data available |
| Disposal | no data available |
Other hazards which do not result in classification
no data available
Handling and Storage
Precautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
France
Australia
United States
Philippines
China
United Kingdom
Hongkong, China
